The meeting discussed the current understanding of the role of immunoglobulin E (IgE) in asthma, and anti-IgE strategies in the treatment of severe asthma.

The objective of this meeting was to review the complexities surrounding the management and treatment options for different populations of chronic…

Prof Windisch opened the symposium on the efficacy of non-invasive ventilation (NIV) in the treatment of chronic obstructive pulmonary disease (COPD).

The 2014 European Respiratory Society International Congress, held last month from 6th-10th September in Munich, Germany, provided a platform for key…

The European Respiratory Society (ERS) International Congress was held in Munich, Germany, on 6th- 10th September 2014, and was a particularly important…

Clinical development of novel therapies for pulmonary artery hypertension (PAH) requires trials of larger patient cohorts, who are studied for longer…

Chronic obstructive pulmonary disease (COPD) is a chronic, progressive, and debilitating disease, particularly in its final stages.

Chronic obstructive pulmonary disease (COPD) is mainly caused by smoking and presents with shortness of breath that is progressive and irreversible.

Increased ambient particulate matter (PM) has been associated with various cardio-respiratory disorders and emergency room visits due to short-term and…

A large number of individuals live in areas of poor air quality, especially in urban environments.Such residency is linked with the exacerbation of asthma..